Browse > Article
http://dx.doi.org/10.1186/s40824-015-0044-0

Haemostatic chitosan coated gauze: in vitro interaction with human blood and in-vivo effectiveness  

Pogorielov, M. (Sumy State University)
Kalinkevich, O. (Institute of Applied Physics)
Deineka, V. (Sumy State University)
Garbuzova, V. (Sumy State University)
Solodovnik, A. (Sumy State University)
Kalinkevich, A. (Institute of Applied Physics)
Kalinichenko, T. (Institute of Applied Physics)
Gapchenko, A. (Sumy State University)
Sklyar, A. (Sumy State Pedagogical University)
Danilchenko, S. (Institute of Applied Physics)
Publication Information
Biomaterials Research / v.19, no.4, 2015 , pp. 218-227 More about this Journal
Abstract
Background: Chitosan and its derivates are widely used for biomedical application due to antioxidative, anti-inflammatory, antimicrobial and tissue repair induced properties. Chitosan-based materials also used as a haemostatic agent but influence of different molecular weight and concentration of chitosan on biological response of blood cells is still not clear. The aim of this research was to evaluate interaction between human blood cells and various forms of chitosan-based materials with different molecular weight and chitosan concentration and prove their effectiveness on in-vivo model. Methods: We used chitosan with molecular weight 200, 500 and 700 kDa and deacetylation rate 80-82 %. For chitosan impregnation of gauze chitosan solutions in 1 % acetic acid with different concentrations (1, 2, 3, 5 %) were used. We used scanning electron microscopy to obtain information about chitosan distribution on cotton surface; Erythrocyte agglutination test and Complete blood count test - for evaluation of interaction between blood cells and chitosan-based materials with different compound. In-vivo studies was performed in 20 Wistar rats to evaluate effectiveness of new dressing. Results: Our data shown that chitosan can bind erythrocytes in concentration-depend manner that does not depend on its molecular weight. In addition, chitosan-based materials affect selectively human blood cells. Composition of chitosan with cotton materials does not change erythrocyte shape and does not cause agglutination. Conclusions: Cotton-chitosan materials have higher adhesive properties to platelets that depend on molecular weight and concentration of chitosan. These materials also change platelets' shape that probable is one of the most important mechanisms of haemostatic effect. In-vivo studies have shown high effectiveness of 2 % 200 kDa chitosan for stop bleeding from arteries of large diameter.
Keywords
Chitosan; Haemostatic dressing; Erythrocytes; Platelets;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Achneck HE, Sileshi B, Jamiolkowski RM, Albala DM, Shapiro ML, Lawson JH. A Comprehensive Review of Topical Hemostatic Agents Efficacy and Recommendations for Use. Ann Surg. 2010;251:217-28.   DOI
2 Bettini R, Romani AA, Morganti MM, Borghetti AF. Physicochemical and cell adhesion properties of chitosan films prepared from sugar and phosphatecontaining solutions. Eur J Pharm Biopharm. 2008;68:74-81.   DOI
3 Brian TG. Effects of Celox and TraumaDEX on Hemorrhage Control in a Porcine Model. AANA Journal. 2010;78(2):115-20.
4 Brown MA, Daya MR, Worley JA. Experience with Chitosan Dressings in a Civilian EMS System. J Emerg Med. 2009;37(1):1-7.   DOI
5 Chou TC, Fu E, Wu CJ, Yeh JH. Chitosan enhances platelet adhesion and aggregation. Biochem and Biophy Res Com. 2003;302:480-3.   DOI
6 Ersoy G, Kaynak MF, Yilmaz O, Rodoplu U, Maltepe F, Gokmen N. Hemostatic effects of microporous polysaccharide hemosphere in a rat model with severe femoral artery bleeding. Adv Ther. 2007;24:485-92.   DOI
7 Hirshberg A, Wall MJ, Ramchandani MK, Mattox KL. Reoperationfor bleeding in trauma. Arch Surg. 1993;128:1163-7.   DOI
8 Kean T, Thanou M. Biodegradation, biodistribution and toxicity of chitosan. Adv Drug Deliv Rev. 2010;62:3-11.   DOI
9 Kind GM, Bines SD, Staren ED, Templeton AJ, Economou SG. Chitosan: evaluation of a new hemostatic agent. Curr Surg. 1990;47:37-9.
10 Klokkevold PR, Fukayama H, Sung EC, Bertolami CN. The effect of chitosan on lingual hemostasis in heparinized rabbits. J Oral Maxillofac Surg. 1999;57:49-52.   DOI
11 Koksal O, Fatma O, Betül CE, Naciye IB, Deniz S. Hemostatic effect of a chitosan linear polymer ($Celox^{(R)}$) in a severe femoral artery bleeding rat model under hypothermia or warfarin therapy. Turkish Journal of Trauma & Emergency Surgery. 2011;17(3):199-204.   DOI
12 Kozen BG. An Alternative Hemostatic Dressing: Comparison of CELOX, HemCon, and QuikClot: Domard A. Influence of the degree of acetylation on some biological properties of chitosan films. Biomaterials. 2000;22:261-8.
13 Larson MJ, Bowersox JC, Lim Jr RC, Hess JR. Efficacy of a fibrin hemostatic bandage in controlling hemorrhage from experimental arterial injuries. Arch Surg. 1995;130:420-2.   DOI
14 Liu X, Ma L, Mao Z, Gao C. Chitosan-based biomaterials for tissue repair and regeneration. Chitosan for biomaterials II. In: Jayakumar R, Prabaharan M, Muzzarelli RAA, editors. Advances in polymer science. Heidelberg: Springer Berlin; 2011. p. 81-127.
15 Madihally SV, Matthew HWT. Porous chitosan scaffolds for tissue engineering. Biomaterials. 1999;20:1133-42.   DOI
16 Mercy HP, Halim AS, Hussein AR. Hitosan-derivatives as hemostatic agents: their role in tissue regeneration. Regen Res. 2012;1:38-46.
17 Neuffer MC, McDivitt J, Rose D, King K, Cloonan CC, Vayer JS. Hemostatic dressings for the first responder: a review. Mil Med. 2004;169:716-20.   DOI
18 Ong S-Y, Wu J, Moochhala SM, Tan M-H, Lu J. Development of a chitosanbased wound dressing with improved hemostatic and antimicrobial properties. Biomaterials. 2008;29:4323-32.   DOI
19 Park BK, Kim MM. Applications of chitin and its derivatives in biological medicine. Int J Mol Sci. 2010;11:5152-64.   DOI
20 Pusateri AE, Holcomb JB, Harris RA, MacPhee MJ, Charles NC, Beall LD, et al. Effect of fibrin bandage fibrinogen concentration on blood loss after grade V liver injury in swine. Mil Med. 2001;166:217-22.   DOI
21 Pusateri AE, Kheirabadi BS, Delgado AV, Doyle JW, Kanellos J, Uscilowicz JM, et al. Structural design of the dry fibrin sealant dressing and its impact on the hemostatic efficacy of the product. J Biomed Mater Res B Appl Biomater. 2004;70:114-21.
22 Pusateri AE, Modrow HE, Harris RA, Holcomb JB, Hess JR, Mosebar RH, et al. Advanced hemostatic dressing development program: animal model selection criteria and results of a study of nine hemostatic dressings in a model of severe large venous hemorrhage and hepatic injury in swine. J Trauma. 2003;55:518-26.   DOI
23 Rao SB, Sharma CP. Use of chitosan as a biomaterial: studies on its safety and hemostatic potential: J. Biomed Mater Res. 1997;34:21-8.   DOI
24 Rhee P, Brown C, Martin M, Salim A, Plurad D, Green D, et al. QuikClot use in trauma for hemorrhage control: case series of 103 documented uses. J Trauma. 2008;64:1093-9.   DOI
25 Rinaudo M. Chitin and chitosan: properties and applications. Prog Polym Sci. 2006;31:603-32.   DOI
26 Sauaia A, Moore FA, Moore EE, Moser KS, Brennan R, Read RA, et al. Epidemiology of traumadeaths: a reassessment. J Trauma. 1995;38:185-93.   DOI
27 Shen EC, Chou TC, Gau CH, Tu HP, Chen YT, Fu E. Releasing growth factors from activated human platelets after chitosan stimulation: a possible biomaterial for platelet-rich plasma preparation. Clin Oral Impl Res. 2006;17:572-8.   DOI
28 Shi C, Zhu Y, Ran X, Wang M, Su Y, Cheng T. Therapeutic Potential of Chitosan and Its Derivatives in Regenerative Medicine. J Surg Res. 2006;133:185-92.   DOI
29 Wedmore I, McManus JG, Pusateri AE, Holcomb JB. A special report on the chitosanbased hemostatic dressing: experience in current combat operations. J Trauma. 2006;60:655-8.   DOI